L
Luxendo
Develops high-tech microscopes
About Luxendo
Luxendo, a Bruker company, specializes in advanced light sheet microscopy solutions designed for fast and high-resolution 3D imaging of live and optically cleared samples. The company serves a diverse range of clients, including research institutions, universities, and pharmaceutical companies, operating primarily in the bioimaging and life sciences markets. Luxendo's business model revolves around the development and sale of specialized microscopy equipment, such as the TruLive3D Imager and QuVi SPIM, which are optimized for multi-sample imaging and long-term fluorescence imaging, respectively. Additionally, Luxendo offers Lux DATA, a comprehensive data processing and storage solution tailored for handling the large volumes of data generated by their microscopes. Revenue is generated through the direct sale of these high-end microscopy systems and associated data solutions, as well as through service contracts and maintenance agreements.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2015
- Headquarters
- Heidelberg, Germany
- Employees
- 14
- Open positions
- None listed
- Dealroom signal
- 73.1/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Spinout, Microscope, DT and LS, science-based
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | May 2017 | $0 | — | Bruker | — |
| SERIES A✓Equity / VC | Jan 2017 | $8.8M | $35M | EQT Life Sciences · EMBL Ventures | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Luxendo is 370 monthly website visits, down 36.2% over the last three months. Luxendo's team grew 40% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
EQT Life Sciences
EMBL Ventures
Other known investors3 additional known investors
Bruker
EMBL
EMBLEM Technology Transfer
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Luxendo on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Luxendo’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.